This site is for health professionals
image
Need an easy way to manage your CPD?

Sign up to Ausmed for Free to take control of your CPD

Cover image for: Insulin Therapy for Type I and Type II Diabetes Mellitus
Details
CPD1h 10m of CPD
First Published
Updated31 January 2018
Expires 14 November 2018
Recorded InMelbourne, Australia

Course Overview

This Course will provide an update on insulin therapy, and the vital role insulin plays in both type 1 and type 2 diabetes mellitus.

Purpose

This Course will provide an update on insulin therapy, and the vital role insulin plays in both type 1 and type 2 diabetes mellitus.

Topics include:

  • Classes of insulin
  • Review of how carbohydrate intake impacts on glucose and insulin levels
  • Modes and uses of insulin
  • Administration of insulin via pump, pen and pre-drawn syringe

Target audience

All healthcare professionals who care for individuals with type 1 and type 2 diabetes who require insulin.

Purpose

Enhance knowledge of insulin therapy by reviewing basic information about insulin, its use, and the administration for the treatment of people with type 1 and type 2 diabetes mellitus.

Need

Insulin is required by all people with type 1 diabetes, as well as by the majority of people with type 2 diabetes after ten years' duration of the condition. It is a high-risk medicine with significant dangers if administered inappropriately. Regular review of the general principles that underlie the prescription and administration of insulin preparations for those with insulin-requiring diabetes mellitus is essential for competent nursing practice and the Quality Use of Medicines (QUM).

Health professionals in Australia that are registered with AHPRA are required to obtain continuing professional development (CPD) hours/points each year that relates to their context of practice, in order to comply with mandatory regulatory requirements.

Learning Outcomes
  • Correlate administration of insulin with current best practice techniques
  • Differentiate between types of insulin in order to effectively individualise treatment for patients
  • Identify issues regarding the safe use of insulin to prevent adverse patient outcomes
Disclosure

No conflict of interest exists for anyone in the position to control content for this activity. Wherever possible, generic or non-proprietary names of medications or products have been used.

Educators

Details
CPD1h 10m of CPD
First Published
Updated31 January 2018
Expires 14 November 2018
Recorded InMelbourne, Australia
Topics
Diabetes Mellitus
Medications
Insulin Therapy
Medication Safety
Diabetic Microvascular Complications
Learning Tools
Content Integrity